Casilda Balmaceda

3.5k total citations
51 papers, 2.4k citations indexed

About

Casilda Balmaceda is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, Casilda Balmaceda has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 19 papers in Oncology and 14 papers in Neurology. Recurrent topics in Casilda Balmaceda's work include Glioma Diagnosis and Treatment (23 papers), Cancer Treatment and Pharmacology (13 papers) and Brain Metastases and Treatment (10 papers). Casilda Balmaceda is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Cancer Treatment and Pharmacology (13 papers) and Brain Metastases and Treatment (10 papers). Casilda Balmaceda collaborates with scholars based in United States, Australia and Argentina. Casilda Balmaceda's co-authors include Jonathan L. Finlay, Lisa M. DeAngelis, Andrew D. Seidman, Michael R. Fetell, Blanca Diez, Linda T. Vahdat, Stewart J. Kellie, Marc K. Rosenblum, Michael B. Sisti and Judith G. Villablanca and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Neurology.

In The Last Decade

Casilda Balmaceda

48 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Casilda Balmaceda United States 26 947 846 719 469 431 51 2.4k
J.‐Y. Delattre France 30 1.5k 1.6× 756 0.9× 1.5k 2.0× 133 0.3× 807 1.9× 64 3.5k
Antonio Silvani Italy 28 1.5k 1.5× 931 1.1× 403 0.6× 158 0.3× 765 1.8× 182 3.3k
Maria Luisa Garrè Italy 33 2.0k 2.1× 495 0.6× 957 1.3× 502 1.1× 582 1.4× 136 3.7k
Irene Slavc Austria 32 1.3k 1.3× 474 0.6× 876 1.2× 235 0.5× 575 1.3× 131 3.2k
Christopher D. Turner United States 25 837 0.9× 513 0.6× 402 0.6× 190 0.4× 501 1.2× 67 2.5k
F. Ann Hayes United States 38 364 0.4× 1.1k 1.2× 2.2k 3.1× 796 1.7× 884 2.1× 64 4.4k
Knut Lote Norway 26 1.4k 1.5× 515 0.6× 504 0.7× 227 0.5× 711 1.6× 60 2.6k
Christof M. Kramm Germany 31 1.4k 1.5× 505 0.6× 790 1.1× 104 0.2× 555 1.3× 100 2.6k
J. M. Bruner United States 26 742 0.8× 600 0.7× 194 0.3× 319 0.7× 266 0.6× 48 2.5k
Alberto Donfrancesco Italy 26 271 0.3× 476 0.6× 752 1.0× 395 0.8× 413 1.0× 82 2.2k

Countries citing papers authored by Casilda Balmaceda

Since Specialization
Citations

This map shows the geographic impact of Casilda Balmaceda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casilda Balmaceda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casilda Balmaceda more than expected).

Fields of papers citing papers by Casilda Balmaceda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casilda Balmaceda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casilda Balmaceda. The network helps show where Casilda Balmaceda may publish in the future.

Co-authorship network of co-authors of Casilda Balmaceda

This figure shows the co-authorship network connecting the top 25 collaborators of Casilda Balmaceda. A scholar is included among the top collaborators of Casilda Balmaceda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casilda Balmaceda. Casilda Balmaceda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Balmaceda, Casilda. (2014). Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. BMC Musculoskeletal Disorders. 15(1). 27–27. 31 indexed citations
4.
Ellis, Jason A., Allen Waziri, Casilda Balmaceda, et al.. (2009). Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients. Journal of Neuro-Oncology. 95(3). 377–382. 58 indexed citations
5.
Balmaceda, Casilda, David M. Peereboom, Susan C. Pannullo, et al.. (2008). Multi‐institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high‐grade gliomas. Cancer. 112(5). 1139–1146. 50 indexed citations
6.
Kim, AeRang, Lingyun Ji, Casilda Balmaceda, et al.. (2008). The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Pediatric Blood & Cancer. 51(6). 768–773. 34 indexed citations
7.
Fine, Robert L., Johnson Chen, Casilda Balmaceda, et al.. (2006). Randomized Study of Paclitaxel and Tamoxifen Deposition into Human Brain Tumors: Implications for the Treatment of Metastatic Brain Tumors. Clinical Cancer Research. 12(19). 5770–5776. 55 indexed citations
8.
Pannullo, Susan C., et al.. (2006). Phase I/II trial of twice-daily temozolomide and celecoxib for treatment of relapsed malignant glioma: Final data. Journal of Clinical Oncology. 24(18_suppl). 1519–1519. 7 indexed citations
9.
Balmaceda, Casilda, Xiangling Mao, Kenneth Cheung, et al.. (2005). Multisection 1H Magnetic Resonance Spectroscopic Imaging Assessment of Glioma Response to Chemotherapy. Journal of Neuro-Oncology. 76(2). 185–191. 31 indexed citations
10.
Balmaceda, Casilda & Jonathan L. Finlay. (2004). Current advances in the diagnosis and management of intracranial germ cell tumors. Current Neurology and Neuroscience Reports. 4(3). 253–262. 28 indexed citations
11.
Savage, David G., J. Gregory Mears, Casilda Balmaceda, et al.. (2002). Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation. Leukemia Research. 26(7). 689–692. 8 indexed citations
12.
Corbo, Massimo, Casilda Balmaceda, & Casilda Balmaceda. (2001). Peripheral Neuropathy in Cancer Patients. Cancer Investigation. 19(4). 369–382. 12 indexed citations
13.
Prestigiacomo, Charles J., Casilda Balmaceda, & Josep Dalmau. (2001). Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma. Cancer. 91(8). 1423–1428. 27 indexed citations
14.
Balmaceda, Casilda. (2000). Chemotherapy for Intramedullary Spinal Cord Tumors. Journal of Neuro-Oncology. 47(3). 293–307. 45 indexed citations
15.
Dalmau, Josep, Sakir H. Gultekin, Raymond Voltz, et al.. (1999). Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain. 122(1). 27–39. 162 indexed citations
16.
Schwartz, Theodore H., Samuel Kim, Emilia Bagiella, et al.. (1999). Supratentorial Ependymomas in Adult Patients. Neurosurgery. 44(4). 721–731. 84 indexed citations
17.
Vahdat, Linda T., Casilda Balmaceda, Thomas F. McGovern, et al.. (1998). Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.. PubMed. 4(7). 1689–95. 23 indexed citations
18.
Fetell, Michael R., Linda T. Vahdat, T. J. Garrett, et al.. (1998). High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplantation. 22(7). 661–667. 13 indexed citations
19.
Hudis, C., Andrew D. Seidman, John Crown, et al.. (1996). Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 14(1). 58–65. 127 indexed citations
20.
Freilich, Ronnie J., Casilda Balmaceda, Andrew D. Seidman, Michael Rubin, & Lisa M. DeAngelis. (1996). Motor neuropathy due to docetaxel and paclitaxel. Neurology. 47(1). 115–118. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.‐Y. Delattre Breakdown of academic impact, for papers by Antonio Silvani Breakdown of academic impact, for papers by Maria Luisa Garrè Breakdown of academic impact, for papers by Irene Slavc Breakdown of academic impact, for papers by Christopher D. Turner Breakdown of academic impact, for papers by F. Ann Hayes Breakdown of academic impact, for papers by Knut Lote Breakdown of academic impact, for papers by Christof M. Kramm Breakdown of academic impact, for papers by J. M. Bruner Breakdown of academic impact, for papers by Alberto Donfrancesco
Rankless by CCL
2026